Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients

Cancer Research

Volumn 58, Issue 3, 1998, Pages 500-503

  Kennedy, Brian P ^a   Soravia, Claudio ^b   Moffat, Jason ^a   Xia, Ling ^b   Hiruki, Tadaaki ^b   Collins, Susan ^a   Gallinger, Steven ^b   Bapat, Bharati ^b,c  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; MESSENGER RNA; PHOSPHOLIPASE A2; PROSTAGLANDIN; SECRETORY PROTEIN;

ADENOMATOUS POLYP; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; CONTROLLED STUDY; DUODENUM POLYP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; ARACHIDONIC ACID; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; DUODENAL NEOPLASMS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MICE; NEOPLASM PROTEINS; PHOSPHOLIPASES A; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0032005173     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediators, 8: 1-30, 1993.
2. 2. Biochem. Biophys. Acta, 1170: 217-213, 1993.
3. 2 in Clinical Inflammation: Molecular Approaches to Pathophysiology. Boca Raton, FL: CRC Press, 1995.
4. 2 added exogenously. J. Biochem., 110: 163-165, 1991.
5. Min-induced intestinal neoplasia. Cell, 81: 957-966, 1995.
6. Moser, A. R., Pilot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Washington DC), 247: 322-324, 1990.
7. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. A germline mutation of the murine homolog of the APC gene causes multiple intestinal neoplasia. Science (Washington DC), 256: 668-670, 1992.
8. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., Markham, A., Krush, A. H., Petersen, G., Hamilton, S. R., Nilbert, M. C., Levy, D. B., Bryan, T. M., Preisinger, A. C., Smith, K. J., Su, L-K., Kinzler, K. W., and Vogelstein, B. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (Washington DC), 253: 665-669, 1991.
9. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spiro, L., Rovertson, M., Sargeant, L., Krapho, K., Wolf, E., Randall, B., Hughes, J. P., Warrington, J., McPherson, J., Wasmith, J., LePasiler, D., Abdererrahmn, H., Cohen, D., Leppert, M., and White, R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
10. 2 gene in inbred mouse strains. J. Biol. Chem., 270: 22378-22385, 1995.
11. Neoptolemos, J. P., Husband, D., Imray, C., Rowley, S., and Lawson, N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut, 32: 278-281, 1991.
12. 2 and diacylglycerol lipase are increased in human colorectal cancer. Br. J. Surg., 82: 475-478, 1995.
13. Rao, C., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
14. Δ716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell, 87: 803-809, 1996.
15. 2 gene alterations in human colorectal cancer. Cancer Res., 55: 5184-5186, 1995.
16. 2 genes that map to human chromosome 1p35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res., 56: 955-958, 1996.
17. 2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis. Hum. Genet., 98: 386-390, 1996.
18. Maniatis, T., Sambrook, J., and Fritsch, E. F. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 7.43-7.52. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
19. 2 expressed in Trichoplusia ni larvae: isolation and kinetic properties of the enzyme. Protein Expression Purif., 4: 490-498, 1993.
20. Cromlish, W. A., Payette, P., Culp, S. A., Ouellet, M., Percival, M. P., and Kennedy, B. P. High-level expression of active human cyclooxygenase-2 in insect cells. Arch. Biochem. Biophys., 314: 193-199, 1994.
21. Xia, L., St. Denis, K. A., and Bapat, B. Evidence for a novel exon in the coding region of the adenomatous polyposis coli (APC) gene. Genomics, 28: 589-591, 1995.
22. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
23. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 75: 4350-4354, 1979.
24. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
25. 2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells. Eur. J. Biochem., 235: 557-563, 1996.
26. Schalkwijk, C. G., Marki, F., Wiesenberg, I., and van den Bosch, H. The detection of multimeric forms of phospholipase A2 upon sodium dodecyl sulfate-polyacrylamide electrophoresis. J. Lipid Mediat., 4: 83-96, 1991.
27. Gould, K. A., Luongo, C., Moser, A. R., McNeley, M. K., Borenstein, N., Shedlovsky, A., Dove, W. F., Hong, K., Dietrich, W. F., and Landers, E. S. Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics, 144: 1777-1785, 1996.
28. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and Dubois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99: 2254-2259, 1997.
29. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
30. 2 shows malignant potential of human breast cancer cells. Cancer (Phila.), 71: 3058-3064, 1993.
31. 2 in human breast cancer tissues is closely associated with their malignant potency. Br. J. Cancer, 69: 1166-1170, 1994.
32. 2 in malignant and non-malignant human gastric mucosa. Br. J. Cancer, 68: 103-111, 1993.
33. 2 in human hepatocellular carcinoma. Biochem. Biophys. Acta, 1226: 201-205, 1993.
34. 2 and cyclooxygenase, in the large bowel mucosa and neoplasms fo F344 rats treated with naturally occurring carcinogen, 1 -hydroxyanthraquinone. Cancer Lett., 97: 75-82, 1995.